Cancer cells under a microscope
Cancer cells under a microscope

The Queensland Institute of Medical Research (QIMR) has been granted permission to manufacture and trial new cancer treatments aimed at rejuvenating patient immune systems, the Australian Broadcasting Corporation (ABC) reported on Monday.

Cancer cells under a microscope
Cancer cells under a microscope

The first Australian facility licensed to produce clinical grade T-cell therapies, the new cancer treatments will take a patient’s immune cells from the blood and train them to recognize antigens found in particular cancers.
Once trained, the cells are re-infused back into the patient to attack the cancer. QIMR tumor immunologist Professor Rajiv Khanna, who developed the treatments, described the approval as exciting saying immunotherapy had great potential to target the spread of secondary cancer.
“When you are treating patients with chemo or radiotherapy, immunotherapy will become part of the normal treatment that is the ultimate goal,” Khanna said. “One of the major advantages of immunotherapy is it is not as nasty or has side effects that the chemotherapy or radiotherapy has.” Enditem

-Xinhua

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.